Hi-Tech Pharmacal Acquires Nystatin Oral Suspension ANDA | Business Wire

Links shared publicly online about this topic.

  • 423
    total visits

Hi-Tech Pharmacal Acquires Nystatin Oral Suspension ANDA | Business Wire

businesswire.com —

Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that it has acquired the rights to the Abbreviated New Drug Application (ANDA) for Nystatin Oral

View full resource at businesswire.com

Tags: Drug, Antifungal Medication, Nystatin

  • Share

Most Recently Shared on March 21, 2011 at 5:58 pm By:

OralHealth_OW Oral Health OW

Hi-Tech Pharmacal Acquires Nystatin Oral Suspension ANDA: AMITYVILLE, N.Y.--(BUSINESS WIRE)--Hi-Tech Pharmacal C... http://bit.ly/fnFEVP

1 year ago...

Reply

Retweet

Favorite

Advertisement